Actavis Inc recalls Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincin…

Recall date

January 30, 2017

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0476-2017

FDA classification

Class II

Brand / firm

Actavis Inc

Sold / distributed

Nationwide in US

Why it was recalled

Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4